Cellebrite DI Ltd.
Cellebrite DI Ltd. (CLBT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLBT · as of Jun 9, 2026
Key Statistics
Explore Cellebrite DI Ltd. Data
clbt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 100.0%
The CLBT analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $19.75, representing +47.06% upside from the current price of $13.43.
Competitors & Peers
clbt competitorsCLBT
BOX
COMP
DLO
DOCN
NAVNStock Performance
Full HistoryAbout Cellebrite DI Ltd.
Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, i…
what is cellebrite di ltd. · clbt stock overview · cellebrite di ltd. company profile · who is cellebrite di ltd. ceo · clbt NASDAQ · cellebrite di ltd. headquarters · cellebrite di ltd. business segments
About Stock Overview & Key Data
Cellebrite DI Ltd. (CLBT) is a Technology company in the Software - Infrastructure industry, listed on NASDAQ since Nov 6, 2020. As of the latest trading session, CLBT stock price is $13.43, with a market capitalization of $3.3B. The stock has returned -19.19% over the past 12 months and -25.51% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Cellebrite DI Ltd. stock is Buy, with an average 12-month price target of $19.75. In fiscal year 2025, Cellebrite DI Ltd. reported revenue of $475.7M and net income of $78.3M. For detailed data — including Cellebrite DI Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cellebrite DI Ltd. (CLBT) stock price is $13.43. The stock is traded on NASDAQ under the ticker symbol CLBT. The 52-week range is $11.02 – $19.98.